Lignospan (Epinephrine, Lidocaine Hydrochloride)

Lignospan is a combination local anesthetic used in the dental field to achieve profound numbness during procedures.

• Periodontal procedures: provides localized anesthesia to facilitate tissue manipulation and scaling.
• Dental extractions: enables painless removal of teeth by blocking nerve transmission.
• Minor oral surgery: offers rapid onset of numbness for incision and suturing in the oral cavity.

• Lidocaine blocks voltage‑gated sodium channels on neuronal membranes, preventing the initiation and propagation of nerve impulses. Epinephrine stimulates alpha‑ and beta‑adrenergic receptors, causing vasoconstriction that limits systemic absorption of lidocaine, prolongs its anesthetic effect, and reduces bleeding at the injection site.

Lignospan may cause a range of adverse reactions, most of which are related to its local anesthetic and vasoconstrictive components.

Common Side Effects

• Transient burning or stinging at the injection site.
• Mild dizziness or light‑headedness.
• Temporary increase in heart rate.
• Localized swelling or bruising.
• Nausea or mild headache.

Serious or Rare Side Effects

• Severe allergic reaction (anaphylaxis) with rash, swelling, or airway compromise.
• Cardiac arrhythmias or hypertension due to epinephrine excess.
• Central nervous system toxicity such as seizures.
• Persistent numbness or paresthesia beyond the expected duration.
• Methemoglobinemia (rare) presenting with cyanosis.

When using Lignospan, clinicians should observe several safety measures to minimize risks.

• Patient assessment: review cardiovascular history and allergy status before administration.
• Dose limitation: avoid exceeding recommended maximum lidocaine dose for the patient.
• Monitoring: observe vital signs after injection, especially in patients with cardiac disease.
• Interaction awareness: consider concomitant sympathomimetic drugs that may amplify epinephrine effects.
• Storage: Store at ambient temperature below 25°C: keep in original container, protect from moisture and direct sunlight.

Lignospan can interact with other medications, altering its safety profile.

Major Interactions (Avoid)

• Non‑selective beta‑blockers: may potentiate bradycardia and hypotension.
• Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis.
• Tricyclic antidepressants: can enhance lidocaine toxicity.

Moderate Interactions (Monitor Closely)

• Sympathomimetic agents (e.g., pseudoephedrine): may augment epinephrine‑induced tachycardia.
• Calcium channel blockers: may affect cardiac response to epinephrine.
• Other local anesthetics: cumulative lidocaine exposure should be tracked.